Biodegradation of 125I-labeled monoclonal antibodies after introvenous administration to rats with experimental C6 glioma

   
Chekhonin V.P.1, Bulanov K.A.2, Yusubalieva G.M.1, Tsibulkina E.A.2, Gurina O.I.1, Skoblov Yu.S.3, Shvets V.I.2, Zhirkov Yu.A.1, P Baklaushev V.1

1. Serbsky National Research Centre for Social and Forensic Psychiatry, Laboratory of Immunochemistry
2. M.V. Lomonosov Moscow State Academy of Fine Chemical Technologies, Department of Biotechnology
3. M.M. Shemyakin & Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences
Section: Experimental/Clinical Study
PubMed Id: 18078067
Year: 2007  Volume: 53  Issue: 5  Pages: 532-540
Employment of radiolabeled antibodies in biological studies, allows their specific accumulation in organs and tissues to be detected. However, stability of such labeled antibodies depends on both the method of labeling and particular experimental conditions. Therefore, stability of labeled antibodies should be determined in every particular experiment. The present paper describes the results obtained in a study of the radiochemical purity and stability of the 125I-labeled conjugates of antibodies to the gliofibrillary acidic protein (GFAP), endothelial antigen AMVB1, and non-specific mouse IgG immediately after their synthesis and at various time points after intravenous administration to rats with experimental C6 glioma. Their stability was determined in the samples of blood, brain, liver, spleen, and kidney by precipitation with trichloroacetic acid. Electrophoretic analysis, thin-layer chromatography, and immunohistochemical tests have proved the radiochemical purity, immunochemical competence, and stability of the labeled antibodies in vivo.
Download PDF:  
Keywords: C6 glioma, biodegradation, radio labeled antibodies, monoclonal antibodies
Citation:

Chekhonin, V. P., Bulanov, K. A., Yusubalieva, G. M., Tsibulkina, E. A., Gurina, O. I., Skoblov, Yu. S., Shvets, V. I., Zhirkov, Yu. A., P, Baklaushev, V. (2007). Biodegradation of 125I-labeled monoclonal antibodies after introvenous administration to rats with experimental C6 glioma. Biomeditsinskaya Khimiya, 53(5), 532-540.
This paper is also available as the English translation: 10.1007/s11828-008-1009-9
References  
 2024 (vol 70)
 2023 (vol 69)
 2022 (vol 68)
 2021 (vol 67)
 2020 (vol 66)
 2019 (vol 65)
 2018 (vol 64)
 2017 (vol 63)
 2016 (vol 62)
 2015 (vol 61)
 2014 (vol 60)
 2013 (vol 59)
 2012 (vol 58)
 2011 (vol 57)
 2010 (vol 56)
 2009 (vol 55)
 2008 (vol 54)
 2007 (vol 53)
 2006 (vol 52)
 2005 (vol 51)
 2004 (vol 50)
 2003 (vol 49)